Companion Diagnostics Market - 2026-2031
Companion Diagnostics Market reached US$6.1 billion in 2022 and is expected to reach US$15.0 billion by 2030, growing with a CAGR of 12.20% during the forecast period 2026-2030.
The Companion Diagnostics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Companion Diagnostics Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Product & Services
Both primary and secondary data sources have been used in the global Companion Diagnostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The Companion Diagnostics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Companion Diagnostics Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Product & Services
- Assays*
- Kits & Reagents
- Software & Services
- Immunohistochemistry (IHC)*
- Polymerase Chain Reaction (PCR)
- In-situ Hybridization (ISH)
- Next-generation Sequencing
- Others
- Cardiovascular*
- Neurological Diseases
- Cancer
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Melanoma
- Gastric Cancer
- Others
- Inflammation and Autoimmune Diseases
- Others
- Pharmaceutical & Biopharmaceutical Companies*
- Contract Research Organizations
- Others
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global Companion Diagnostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Product & Services
3.2. Snippet by Technology
3.3. Snippet by Indication
3.4. Snippet by End User
3.5. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Advancing Novel Frameworks for Companion Diagnostics
4.1.1.2. Growing Partnerships for Advance Next-Generation Sequencing Companion Diagnostics
4.1.2. Restraints
4.1.2.1. Challenges Associated with Companion Diagnostic Development
4.1.3. Opportunity
4.1.3.1. Collaboration and Innovation Among Market Players
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. RUSSIA-UKRAINE WAR ANALYSIS
8. BY PRODUCT & SERVICES
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services
8.1.2. Market Attractiveness Index, By Product & Services
8.2. Assays*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Kits & Reagents
8.4. Software & Services
9. BY TECHNOLOGY
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.1.2. Market Attractiveness Index, By Technology
9.2. Immunohistochemistry (IHC)*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Polymerase Chain Reaction (PCR)
9.4. In-situ Hybridization (ISH)
9.5. Next-generation Sequencing
9.6. Others
10. BY INDICATION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.1.2. Market Attractiveness Index, By Indication
10.2. Cardiovascular*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Neurological Diseases
10.4. Cancer
10.4.1. Breast Cancer
10.4.2. Lung Cancer
10.4.3. Colorectal Cancer
10.4.4. Melanoma
10.4.5. Gastric Cancer
10.4.6. Others
10.5. Inflammation and Autoimmune Diseases
10.6. Others
11. BY END USER
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Pharmaceutical & Biopharmaceutical Companies*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Contract Research Organizations
11.4. Others
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.2.7.1. U.S.
12.2.7.2. Canada
12.2.7.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.3.7.1. Germany
12.3.7.2. U.K.
12.3.7.3. France
12.3.7.4. Italy
12.3.7.5. Spain
12.3.7.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.4.7.1. Brazil
12.4.7.2. Argentina
12.4.7.3. Rest of South America
12.5. Asia Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.5.7.1. China
12.5.7.2. India
12.5.7.3. Japan
12.5.7.4. Australia
12.5.7.5. Rest of Asia Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
13. COMPETITIVE LANDSCAPE
13.1. Competitive Scenario
13.2. Product Benchmarking
13.3. Company Share Analysis
13.4. Key Developments and Strategies
14. COMPANY PROFILES
14.1. F. Hoffmann-La Roche Ltd. *
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Agilent Technologies, Inc.
14.3. Qiagen N.V.
14.4. Thermo Fisher Scientific, Inc.
14.5. Abbott Laboratories, Inc.
14.6. Biomerieux SA
14.7. Siemens Healthcare
14.8. Thermo Fisher Scientific Inc.
14.9. Danaher Corporation (Beckman Coulter Inc.)
14.10. Guardant Health
14.11. Illumina Inc. (*LIST NOT EXHAUSTIVE)
15. APPENDIX
15.1. About Us and Services
15.2. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Product & Services
3.2. Snippet by Technology
3.3. Snippet by Indication
3.4. Snippet by End User
3.5. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Advancing Novel Frameworks for Companion Diagnostics
4.1.1.2. Growing Partnerships for Advance Next-Generation Sequencing Companion Diagnostics
4.1.2. Restraints
4.1.2.1. Challenges Associated with Companion Diagnostic Development
4.1.3. Opportunity
4.1.3.1. Collaboration and Innovation Among Market Players
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. RUSSIA-UKRAINE WAR ANALYSIS
8. BY PRODUCT & SERVICES
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Services
8.1.2. Market Attractiveness Index, By Product & Services
8.2. Assays*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Kits & Reagents
8.4. Software & Services
9. BY TECHNOLOGY
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.1.2. Market Attractiveness Index, By Technology
9.2. Immunohistochemistry (IHC)*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Polymerase Chain Reaction (PCR)
9.4. In-situ Hybridization (ISH)
9.5. Next-generation Sequencing
9.6. Others
10. BY INDICATION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.1.2. Market Attractiveness Index, By Indication
10.2. Cardiovascular*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Neurological Diseases
10.4. Cancer
10.4.1. Breast Cancer
10.4.2. Lung Cancer
10.4.3. Colorectal Cancer
10.4.4. Melanoma
10.4.5. Gastric Cancer
10.4.6. Others
10.5. Inflammation and Autoimmune Diseases
10.6. Others
11. BY END USER
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Pharmaceutical & Biopharmaceutical Companies*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Contract Research Organizations
11.4. Others
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.2.7.1. U.S.
12.2.7.2. Canada
12.2.7.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.3.7.1. Germany
12.3.7.2. U.K.
12.3.7.3. France
12.3.7.4. Italy
12.3.7.5. Spain
12.3.7.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.4.7.1. Brazil
12.4.7.2. Argentina
12.4.7.3. Rest of South America
12.5. Asia Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.5.7.1. China
12.5.7.2. India
12.5.7.3. Japan
12.5.7.4. Australia
12.5.7.5. Rest of Asia Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Services
12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
13. COMPETITIVE LANDSCAPE
13.1. Competitive Scenario
13.2. Product Benchmarking
13.3. Company Share Analysis
13.4. Key Developments and Strategies
14. COMPANY PROFILES
14.1. F. Hoffmann-La Roche Ltd. *
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Agilent Technologies, Inc.
14.3. Qiagen N.V.
14.4. Thermo Fisher Scientific, Inc.
14.5. Abbott Laboratories, Inc.
14.6. Biomerieux SA
14.7. Siemens Healthcare
14.8. Thermo Fisher Scientific Inc.
14.9. Danaher Corporation (Beckman Coulter Inc.)
14.10. Guardant Health
14.11. Illumina Inc. (*LIST NOT EXHAUSTIVE)
15. APPENDIX
15.1. About Us and Services
15.2. Contact Us
